What is the current price and recent move for 2228.HK stock?

2228.HK stock trades at **HK$13.48** pre-market on 24 Jan 2026, up **4.50%** for the day with volume **88,148,228**. The 50-day average price is **HK$10.54** and the 200-day average is **HK$8.49**.

How does Meyka AI rate XtalPi (2228.HK)?

Meyka AI rates 2228.HK **58.79 out of 100**, grade **C+** with a **HOLD** suggestion. The score factors S&P 500 and sector comparisons, key metrics, growth forecasts, and analyst signals.

What are the short-term and 12-month forecasts for 2228.HK stock?

Meyka AI's forecast model projects **monthly HK$16.04** (about **+18.99%** vs current) and **12-month HK$10.46** (about **-22.41%**). These are model outputs, not guaranteed outcomes.

What are the main risks for investors in 2228.HK stock?

Main risks include negative operating margins, stretched cash conversion cycles, high price-to-sales multiples, and dependency on successful AI-drug partnerships. Monitor quarterly cash flow and contract updates closely.

HK Stocks

2228.HK stock trades at HK$13.48 pre-market HKSE 24 Jan 2026: AI growth vs near-term risks

ByDanny Kontos January 24, 2026January 24, 2026

2228.HK stock trades at HK$13.48 pre-market, up 4.50%, on 24 Jan 2026. XtalPi Holdings Ltd (2228.HK) on the HKSE is drawing attention after a strong volume day of 88,148,228 shares and a bounce above the 50-day average of HK$10.54. We look at valuation, technical momentum, and AI-drug discovery catalysts to frame a practical trading view for Hong Kong investors using Meyka AI-powered market analysis platform.